Connect with us

Press Releases

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full scope approach reflects global growth and ECP-centric focus




Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Karen Walsh, Senior Director, Global Professional Affairs, CooperVision

(PRESS RELEASE) SAN RAMON, CA—Responding to its continued global growth and expanding partnerships with eye care professionals (ECPs) worldwide, CooperVision today announced the creation of a unified, full scope Global Professional Affairs organization. The group will be led by Karen Walsh, MCOptom, PGDip, FAAO, FIACLE, FBCLA, who has been promoted to Senior Director in conjunction with the development.

“ECPs are central to patient prescribing choices and influential advocates whose views and decisions shape the contact lens category. Establishing a singular, ECP-led Global Professional Affairs team will better inform our product development, commercialization strategies, scientific publishing, product support and education outreach,” said Simon Seshadri, Senior Vice President, Global Marketing & Life Cycle Management, CooperVision. “Working hand-in-hand with their regional Professional Affairs colleagues, Karen’s group will help CooperVision colleagues and our customers thrive as the eye care and ocular health sectors evolve.”

Karen Walsh, Senior Director, Global Professional Affairs, CooperVision

Dr. Walsh is a widely recognized ophthalmic opinion leader. Prior to joining CooperVision in 2021, she built international acclaim as an educator, researcher, and author at the Centre for Ocular Research and Education (CORE) at the University of Waterloo. Following a decade working in clinical contact lens-focused practice, she also served with Johnson & Johnson Vision as Professional Affairs Manager for the U.K. & Ireland. Dr. Walsh is a Fellow of the American Academy of Optometry, the International Association of Contact Lens Educators, and the British Contact Lens Association. She also is a member of the U.K. College of Optometrists and holds a post-graduate diploma in clinical optometry from City University, London.

During her CooperVision tenure, Dr. Walsh has been instrumental in translating scientific knowledge into clinical practice for the MyDay®, clariti®, Biofinity®, and Avaira Vitality™ contact lens brand portfolios, as well as cultivating information and insights from ECPs worldwide to support strategic planning. She has continued to be an in-demand speaker at CooperVision customer events as well as prominent industry conferences.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines






Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular